The clinical and ecological impact of childhood pneumococcal vaccination

British Journal of Hospital Medicine

Volumn 74, Issue 4, 2013, Pages 212-216

  Gil, Eliza ^a   Noursadeghi, Mahdad ^a   Brown, Jeremy S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876361195     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2013.74.4.212     Document Type: Article

References (36)

1. Ampofo K, Pavia AT, Chris, S et al (2012) The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J 31: 228-34
2. Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, George R, Lim WS (2012) Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax 67: 540-5
3. Bingen E, Levy C, Varon E et al (2008) Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation. Eur J Clin Microbiol Infect Dis 27: 191-9
4. Brown JS (2012) Pneumococcal capsular serotypes and lung infection. Thorax 67: 473-4
5. Brueggemann AB, Peto TEA, Crook DW, Butler JC, Kristinsson KG, Spratt BG (2004) Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 190: 1203-11 (Pubitemid 39287745)
6. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, Swartz MN (1993) Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328: 21-8 (Pubitemid 23011467)
7. Golubchik T, Brueggemann AB, Street T et al (2012) Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event. Nat Genet 44: 352-5
8. Grabenstein JD, Klugman KP (2012) A century of pneumococcal vaccination research in humans. Clin Microbiol Infect 18: 15-24
9. Grijalva CG, Poehling KA, Nuorti JP, Zhu Y, Martin SW, Edwards KM, Griffin MR (2006) National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics 118: 865-73 (Pubitemid 46090026)
10. Grijalva CG, Moore MR, Griffin MR (2011) Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data Lancet Infect Dis 11: 724-6
11. Hanquet G, Kissling E, Fenoll A et al (2010) Pneumococcal serotypes in children in 4 European countries. Emerging Infect Dis 16: 1428-39
12. Hausdorff WP, Van Dyke MK, Van Effelterre T (2012) Serotype replacement after pneumococcal vaccination. Lancet 379: 1387-8; author reply 1388-9
13. Henrichsen J (1995) Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 33: 2759-62
14. Horácio AN, Diamantino-Miranda J, Aguiar SI, Ramirez M, Melo- Cristino J (2012) Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections. Vaccine 30: 218-24
15. Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA (2005) Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116: e408-13 (Pubitemid 44336655)
16. Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC (2012) Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine 30: 3503-14
17. Kaplan SL, Barson WJ, Lin PL et al (2010) Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics 125: 429-36
18. Knuf M, Kowalzik F, Kieninger D (2011) Comparative effects of carrier proteins on vaccine-induced immune response. Vaccine 29: 4881-90
19. Leal J, Vanderkooi OG, Church DL, Macdonald J, Tyrrell GJ, Kellner JD (2012) Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta. Pediatr Infect Dis J 31: e169-75
20. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, Saikku P (2001) Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 56: 296-301 (Pubitemid 32269810)
21. Miller E, Andrews NJ, Waight PA, Slack MP, George RC (2011) Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 11: 760-8
22. Moore MR, Gertz RE Jr, Woodbury RL et al (2008) Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197: 1016-27 (Pubitemid 351590031)
23. Muñoz-Almagro C, Esteva C, De Sevilla MF, Selva L, Gene A, Pallares R (2009) Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. J Infect 59: 75-82
24. Parsons HK, Dockrell DH (2002) The burden of invasive pneumococcal disease and the potential for reduction by immunisation. Int J Antimicrob Agents 19: 85-93 (Pubitemid 34168175)
25. Pilishvili T, Lexau C, Farley MM et al (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201: 32-41
26. Reinert R, Jacobs MR, Kaplan SL (2010) Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine 28: 4249-59
27. Song J-H, Dagan R, Klugman KP, Fritzell B (2012) The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 30: 2728-37
28. Thomas MF, Sheppard CL, Guiver M et al (2012) Emergence of pneumococcal 19A empyema in UK children. Arch Dis Child 97: 1070-2
29. Trotter CL, Waight P, Andrews NJ, Slack M, Efstratiou A, George R, Miller E (2010) Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006. J Infect 60: 200-8
30. Van der Linden M, Weiß S, Falkenhorst G, Siedler A, Imöhl M, Von Kries R (2012) Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children. Vaccine 30: 5880-5
31. Vergison A, Hanquet G (2012) Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance. Pediatr Infect Dis J 31: 400-3
32. Weil-Olivier C, Van der Linden M, De Schutter I, Dagan R, Mantovani L (2012) Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective. BMC Infect Dis 12: 207
33. Weinberger DM, Harboe ZB, Sanders EAM et al (2010) Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 51: 692-9
34. Weinberger DM, Malley R, Lipsitch M (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 378: 1962-73
35. Wenger J, Zulz T, Bruden D et al (2010) Invasive pneumococcal disease in Alaskan children: impact of the seven-valent pneumococcal conjugate vaccine and the role of water supply. Pediatr Infect Dis J 29: 251-6
36. World Health Organization (2012) Estimated Hib and pneumococcal deaths for children under 5 years of age, 2008. www.who.int/immunization-monitoring/ burden/Pneumo-hib-estimates/en/index.html (accessed 18 July 2012)